Literature DB >> 18321863

Stabilization of RelB requires multidomain interactions with p100/p52.

Amanda J Fusco1, Olga V Savinova, Rashmi Talwar, Jeffrey D Kearns, Alexander Hoffmann, Gourisankar Ghosh.   

Abstract

The NF-kappaB family member RelB has many properties not shared by other family members such as restricted subunit association and lack of regulation by the classical IkappaB proteins. We show that the protein level of RelB is significantly reduced in the absence of p100 and reduced even more when both p100 and p105 are absent. RelB stabilizes itself by directly interacting with p100, p105, and their processed products. However, RelB forms complexes with its partners using different interaction modes. Although the C-terminal ankyrin repeat domain of p105 is not involved in the RelB-p105 complex formation, all domains and flexible regions of each protein are engaged in the RelB-p100 complex. In several respects the RelB-p52 and RelB-p100 complexes are unique in the NF-kappaB family. The N-terminal domain of p100/p52 interacts with RelB but not RelA. The transcriptional activation domain of RelB, but not RelA, directly interacts with the processing region of p100. These unique protein-protein contacts explain why RelB prefers p52 as its dimeric partner for transcriptional activity and is retained in the cytoplasm as an inhibited complex by p100. This association-mediated stabilization of RelB implies a possible role for RelB in the processing of p100 into p52.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321863      PMCID: PMC2431000          DOI: 10.1074/jbc.M707898200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  RelB cellular regulation and transcriptional activity are regulated by p100.

Authors:  Nancie J Solan; Hiroko Miyoshi; Eva M Carmona; Gary D Bren; Carlos V Paya
Journal:  J Biol Chem       Date:  2001-10-30       Impact factor: 5.157

3.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

Review 4.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

5.  NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.

Authors:  G Xiao; E W Harhaj; S C Sun
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

6.  Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control.

Authors:  R Marienfeld; F Berberich-Siebelt; I Berberich; A Denk; E Serfling; M Neumann
Journal:  Oncogene       Date:  2001-12-06       Impact factor: 9.867

7.  Ikappa Balpha functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-kappaB.

Authors:  S Malek; T Huxford; G Ghosh
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

8.  Genetic evidence for the essential role of beta-transducin repeat-containing protein in the inducible processing of NF-kappa B2/p100.

Authors:  Abraham Fong; Shao-Cong Sun
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

9.  Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.

Authors:  Gad Asher; Joseph Lotem; Leo Sachs; Chaim Kahana; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-13       Impact factor: 11.205

10.  BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

Authors:  Estefania Claudio; Keith Brown; Sun Park; Hongshan Wang; Ulrich Siebenlist
Journal:  Nat Immunol       Date:  2002-09-23       Impact factor: 25.606

View more
  39 in total

1.  Classical NF-kappaB activation negatively regulates noncanonical NF-kappaB-dependent CXCL12 expression.

Authors:  Lisa A Madge; Michael J May
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  An alternative to lung inflammation and fibrosis.

Authors:  Gilbert F Morris
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

Review 3.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

4.  NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes.

Authors:  Amanda J Fusco; De-Bin Huang; Dustyn Miller; Vivien Ya-Fan Wang; Don Vu; Gourisankar Ghosh
Journal:  EMBO Rep       Date:  2008-12-19       Impact factor: 8.807

Review 5.  RelB: an outlier in leukocyte biology.

Authors:  Patrick Millet; Charles McCall; Barbra Yoza
Journal:  J Leukoc Biol       Date:  2013-08-06       Impact factor: 4.962

6.  Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity.

Authors:  Jin Jin; Hongbo Hu; Haiyan S Li; Jiayi Yu; Yichuan Xiao; George C Brittain; Qiang Zou; Xuhong Cheng; Frédérick A Mallette; Stephanie S Watowich; Shao-Cong Sun
Journal:  Immunity       Date:  2014-03-20       Impact factor: 31.745

7.  Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection.

Authors:  Balaji Banoth; Budhaditya Chatterjee; Bharath Vijayaragavan; M V R Prasad; Payel Roy; Soumen Basak
Journal:  Elife       Date:  2015-04-23       Impact factor: 8.140

8.  IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors.

Authors:  Hélène Authier; Katy Billot; Emmanuel Derudder; Didier Bordereaux; Pierre Rivière; Sylvie Rodrigues-Ferreira; Clara Nahmias; Véronique Baud
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

9.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

10.  Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling.

Authors:  M Hahn; J-P Bürckert; C A Luttenberger; S Klebow; M Hess; M Al-Maarri; M Vogt; S Reißig; M Hallek; A Wienecke-Baldacchino; T Buch; C P Muller; C P Pallasch; F T Wunderlich; A Waisman; N Hövelmeyer
Journal:  Leukemia       Date:  2017-06-01       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.